Greenwich Lifesciences Inc (GLSI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $219.29M
Last updated: Nov 17, 2026 at 11:05 AM ET
Greenwich Lifesciences Inc (GLSI) Earnings: Report Dates and Results
Greenwich Lifesciences (GLSI) is expected to report earnings on Jun 2, 2027. In the quarter ended Jun 30, 2026, Greenwich Lifesciences reported EPS of -$0.27, above the -$0.33 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
GLSI has an expected report date of Jun 2, 2027.
Earnings History
Of the 24 quarters below that had an estimate, GLSI beat 14, missed 7 and matched 3. The widest gap in the table came in the quarter ended Dec 31, 2024, when EPS landed 190.48% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.27 | -$0.33 | -$0.36 - -$0.30 | +18.18% | Beat | N/A | 2 | 0 up, 0 down | Aug 11, 2026 |
| Mar 31, 2026 | -$0.39 | -$0.32 | N/A | -21.88% | Miss | N/A | 1 | 0 up, 0 down | Jun 3, 2026 |
| Dec 31, 2025 | -$0.58 | -$0.34 | -$0.34 - -$0.30 | -70.59% | Miss | N/A | 2 | 0 up, 0 down | Mar 31, 2026 |
| Sep 30, 2025 | -$0.30 | -$0.36 | -$0.36 - -$0.36 | +16.67% | Beat | N/A | 1 | 0 up, 0 down | Nov 14, 2025 |
| Jun 30, 2025 | -$0.30 | -$0.24 | N/A | -25.00% | Miss | N/A | N/A | 0 up, 0 down | Aug 14, 2025 |
| Mar 31, 2025 | -$0.25 | -$0.24 | N/A | -4.17% | Miss | N/A | N/A | 0 up, 0 down | Apr 15, 2025 |
| Dec 31, 2024 | -$0.61 | -$0.21 | N/A | -190.48% | Miss | N/A | N/A | 0 up, 0 down | Feb 26, 2025 |
| Sep 30, 2024 | -$0.20 | -$0.21 | -$0.21 - -$0.21 | +4.76% | Beat | N/A | 1 | 0 up, 1 down | Nov 14, 2024 |
| Jun 30, 2024 | -$0.20 | -$0.20 | N/A | 0.00% | In line | N/A | N/A | 0 up, 0 down | Aug 14, 2024 |
| Mar 31, 2024 | -$0.19 | -$0.20 | -$0.20 - -$0.20 | +5.00% | Beat | N/A | 1 | 0 up, 0 down | Apr 15, 2024 |
| Dec 31, 2023 | -$0.21 | -$0.22 | N/A | +2.82% | Beat | N/A | 1 | 0 up, 0 down | Mar 31, 2024 |
| Sep 30, 2023 | -$0.19 | -$0.22 | N/A | +13.64% | Beat | N/A | N/A | 0 up, 0 down | Oct 19, 2023 |
| Jun 30, 2023 | -$0.13 | -$0.23 | -$0.23 - -$0.23 | +43.48% | Beat | N/A | 1 | 0 up, 0 down | Aug 21, 2023 |
| Mar 31, 2023 | -$0.17 | -$0.23 | -$0.23 - -$0.23 | +26.09% | Beat | N/A | 1 | 0 up, 0 down | May 22, 2023 |
| Dec 31, 2022 | -$0.22 | -$0.22 | N/A | 0.00% | In line | N/A | 1 | 0 up, 0 down | Mar 31, 2023 |
| Sep 30, 2022 | -$0.18 | -$0.19 | -$0.19 - -$0.19 | +5.26% | Beat | N/A | 1 | 0 up, 0 down | Nov 14, 2022 |
| Jun 30, 2022 | -$0.06 | -$0.19 | -$0.19 - -$0.19 | +68.42% | Beat | N/A | 1 | 0 up, 0 down | Aug 15, 2022 |
| Mar 31, 2022 | -$0.15 | -$0.19 | -$0.19 - -$0.19 | +21.05% | Beat | N/A | 1 | 0 up, 0 down | May 20, 2022 |
| Dec 31, 2021 | -$0.18 | -$0.07 | -$0.07 - -$0.07 | -157.14% | Miss | N/A | 1 | 0 up, 0 down | Mar 21, 2022 |
| Sep 30, 2021 | -$0.07 | -$0.06 | -$0.06 - -$0.06 | -16.67% | Miss | N/A | 1 | N/A | Nov 15, 2021 |
| Jun 30, 2021 | -$0.06 | -$0.32 | N/A | +81.25% | Beat | N/A | N/A | N/A | Aug 13, 2021 |
| Mar 31, 2021 | -$0.05 | -$0.32 | N/A | +84.38% | Beat | N/A | 1 | N/A | May 20, 2021 |
| Dec 31, 2020 | -$0.12 | -$0.93 | -$0.93 - -$0.93 | +87.10% | Beat | N/A | 1 | N/A | Mar 31, 2021 |
| Sep 30, 2020 | -$0.03 | -$0.03 | N/A | 0.00% | In line | N/A | N/A | N/A | Nov 16, 2020 |
| Jun 30, 2020 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 28, 2020 |
| Mar 31, 2020 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 23, 2020 |
| Dec 31, 2019 | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jan 28, 2020 |
| Jun 30, 2019 | -$1.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2019 |
| Mar 31, 2019 | -$12.83 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2019 |
| Dec 31, 2018 | -$0.73 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2019 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.43, after -$1.20 the year before. It was -$0.73 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.43 | N/A |
| Dec 31, 2024 | -$1.20 | N/A |
| Dec 31, 2023 | -$0.70 | N/A |
| Dec 31, 2022 | -$0.61 | N/A |
| Dec 31, 2021 | -$0.36 | N/A |
| Dec 31, 2020 | -$0.19 | N/A |
| Dec 31, 2019 | -$14.25 | N/A |
| Dec 31, 2018 | -$0.73 | N/A |
Frequently Asked Questions About GLSI
When is Greenwich Lifesciences's next earnings date?
Greenwich Lifesciences's next earnings report is expected for Jun 2, 2027.
Did GLSI beat earnings estimates last quarter?
Yes. Greenwich Lifesciences reported EPS of -$0.27 for the quarter ended Jun 30, 2026, above the -$0.33 estimate, a 18.18% surprise.
What EPS do analysts expect from GLSI next quarter?
The consensus EPS estimate for Greenwich Lifesciences for the quarter ending Dec 31, 2026 is -$0.36 from 4 analysts, with estimates from -$0.39 to -$0.32.
How often does GLSI beat earnings estimates?
Greenwich Lifesciences beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -34.06%.
GLSI pages: Overview, Earnings, Forecast, Financials, Competitors